Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06878872 · ClinicalTrials.gov registry record · NA
Type 1 Diabetes Adolescents for Healthier Lifestyles Study
A NA study, sponsored by The Miriam Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT06878872 is a NA study that is actively recruiting participants, run by The Miriam Hospital. The registered enrollment target is 50 participants.
The verdict
NCT06878872, a NA study, is actively recruiting participants, sponsored by The Miriam Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Before the 1990s, obesity was rare among young people with type 1 diabetes (T1D), but now it is more common. Recent studies show that over 50% of young people with T1D will have overweight or obesity within five years of being diagnosed with T1D. Both obesity and T1D increase the risk of heart disease, and combined, these risks are even higher. Intensive health behavior and lifestyle treatments (IHBLTs) are proven to be effective for treating childhood obesity. However, managing T1D creates unique challenges that require adjustments to these treatments. For example, people with T1D need to eat even when they're not hungry to treat low blood sugar, blood sugar changes can make exercise harder, and some recommended "free foods" are high in unhealthy fats. Young people with T1D are also more likely to develop eating disorders. There is a need for IHBLTs that address these specific challenges and focus on preventing eating disorders in this group. To address these needs, we developed the Type 1 Diabetes Adolescents for healthier Lifestyles (T1DAL) program, based on feedback from teenagers with T1D, their parents/caregivers, and pediatric endocrinologists. The goal of this study is to test whether the T1DAL program can improve the health and wellbeing of teens compared to usual care. In this study, about 50 teens will be randomly assigned to either the T1DAL program or to Usual Care. Those in the T1DAL group will take part in a 16-week program designed specifically for teens with T1D to improve eating habits and diabetes management. Those in the Usual Care group will continue with their regular endocrinology appointments. At the end of the study, the Usual Care group will be offered a shortened version of the T1DAL program. All participants will have their height, weight, blood glucose, eating habits, diabetes management behaviors, and mood measured at the start and end of the study. They will also answer questions to track unhealthy eating and weight control behaviors
Interventions
- BEHAVIORAL T1DAL Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06878872
The ClinicalTrials.gov registry entry for NCT06878872 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Miriam Hospital, which has 136 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which T1DAL Program is the first listed.
NCT06878872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06878872 about?
NCT06878872 is a clinical study titled "Type 1 Diabetes Adolescents for Healthier Lifestyles Study". Before the 1990s, obesity was rare among young people with type 1 diabetes (T1D), but now it is more common. Recent studies show that over 50% of young people with T1D will have overweight or obesity within five years of being diagnosed with T1D. Both obesity and T1D increase the risk of heart disea...
What is the current status of trial NCT06878872?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-08-01. Estimated completion is 2027-06-01.
What interventions are being tested in trial NCT06878872?
The interventions under investigation include: T1DAL Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06878872?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.